PE20040894A1 - Agonistas muscarinicos - Google Patents
Agonistas muscarinicosInfo
- Publication number
- PE20040894A1 PE20040894A1 PE2003000851A PE2003000851A PE20040894A1 PE 20040894 A1 PE20040894 A1 PE 20040894A1 PE 2003000851 A PE2003000851 A PE 2003000851A PE 2003000851 A PE2003000851 A PE 2003000851A PE 20040894 A1 PE20040894 A1 PE 20040894A1
- Authority
- PE
- Peru
- Prior art keywords
- objectives
- refers
- compound
- muscarine
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE REFIERE AL COMPUESTO HEMIDRATO CRISTALINO DE (R)-(6-(1-((4-FLUOROBENCIL)METILAMINO)ETILIDENOAMINO)-2(R)-HIDROXIINDAN-1-IL)AMIDA DEL ACIDO BIFENIL-4-CARBOXILICO QUE TIENE UN PATRON DE DIFRACCION DE RAYOS X EN POLVO CON UN PICO DE 5,2; 6,2; 12,6; 14,0; 15,6; 17,0; 18,8; 19,6; 20,0; 22,6 (±0,1° 2q). SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA EN LA QUE DICHO COMPUESTO ES AGONISTA SELECTIVO DEL RECEPTOR M-1 MUSCARINICO UTILES EN EL TRATAMIENTO DE DIVERSOS TRASTORNOS DEL SISTEMA NERVIOSO CENTRAL COMO TRASTORNOS COGNITIVOS, OBESIDAD, ENFERMEDAD DE ALZHEIMER, PSICOSIS, ENTRE OTROS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40544302P | 2002-08-22 | 2002-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040894A1 true PE20040894A1 (es) | 2004-11-25 |
Family
ID=31946873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000851A PE20040894A1 (es) | 2002-08-22 | 2003-08-21 | Agonistas muscarinicos |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7160922B2 (es) |
| EP (1) | EP1534667B1 (es) |
| JP (1) | JP4469280B2 (es) |
| CN (1) | CN100554247C (es) |
| AR (1) | AR040889A1 (es) |
| AT (1) | ATE491683T1 (es) |
| AU (1) | AU2003256791B2 (es) |
| BR (1) | BR0313161A (es) |
| CA (1) | CA2493958C (es) |
| CY (1) | CY1111115T1 (es) |
| DE (1) | DE60335380D1 (es) |
| DK (1) | DK1534667T3 (es) |
| ES (1) | ES2355213T3 (es) |
| MX (1) | MXPA05002080A (es) |
| PE (1) | PE20040894A1 (es) |
| PT (1) | PT1534667E (es) |
| SI (1) | SI1534667T1 (es) |
| TW (1) | TW200410922A (es) |
| WO (1) | WO2004018411A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2275095A3 (en) * | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| JP2013523679A (ja) | 2010-03-29 | 2013-06-17 | ビーエーエスエフ ソシエタス・ヨーロピア | 殺菌性イミノ誘導体 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040053130A (ko) * | 2001-09-21 | 2004-06-23 | 일라이 릴리 앤드 캄파니 | 무스카린성 효능제 |
-
2003
- 2003-08-12 BR BR0313161-0A patent/BR0313161A/pt not_active IP Right Cessation
- 2003-08-12 ES ES03792989T patent/ES2355213T3/es not_active Expired - Lifetime
- 2003-08-12 CN CNB038192500A patent/CN100554247C/zh not_active Expired - Fee Related
- 2003-08-12 WO PCT/US2003/023260 patent/WO2004018411A1/en active Application Filing
- 2003-08-12 DK DK03792989.0T patent/DK1534667T3/da active
- 2003-08-12 EP EP03792989A patent/EP1534667B1/en not_active Expired - Lifetime
- 2003-08-12 PT PT03792989T patent/PT1534667E/pt unknown
- 2003-08-12 US US10/524,960 patent/US7160922B2/en not_active Expired - Fee Related
- 2003-08-12 AU AU2003256791A patent/AU2003256791B2/en not_active Ceased
- 2003-08-12 SI SI200331933T patent/SI1534667T1/sl unknown
- 2003-08-12 CA CA2493958A patent/CA2493958C/en not_active Expired - Fee Related
- 2003-08-12 DE DE60335380T patent/DE60335380D1/de not_active Expired - Lifetime
- 2003-08-12 AT AT03792989T patent/ATE491683T1/de active
- 2003-08-12 MX MXPA05002080A patent/MXPA05002080A/es active IP Right Grant
- 2003-08-12 JP JP2004530846A patent/JP4469280B2/ja not_active Expired - Fee Related
- 2003-08-20 TW TW092122893A patent/TW200410922A/zh unknown
- 2003-08-20 AR AR20030103011A patent/AR040889A1/es unknown
- 2003-08-21 PE PE2003000851A patent/PE20040894A1/es not_active Application Discontinuation
-
2011
- 2011-01-19 CY CY20111100057T patent/CY1111115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004018411A1 (en) | 2004-03-04 |
| MXPA05002080A (es) | 2005-08-18 |
| EP1534667B1 (en) | 2010-12-15 |
| BR0313161A (pt) | 2005-06-14 |
| CY1111115T1 (el) | 2015-06-11 |
| TW200410922A (en) | 2004-07-01 |
| JP4469280B2 (ja) | 2010-05-26 |
| ATE491683T1 (de) | 2011-01-15 |
| AU2003256791B2 (en) | 2008-12-11 |
| CA2493958A1 (en) | 2004-03-04 |
| JP2005536549A (ja) | 2005-12-02 |
| PT1534667E (pt) | 2011-01-19 |
| AR040889A1 (es) | 2005-04-20 |
| ES2355213T3 (es) | 2011-03-23 |
| DE60335380D1 (de) | 2011-01-27 |
| US7160922B2 (en) | 2007-01-09 |
| SI1534667T1 (sl) | 2011-02-28 |
| CN1675173A (zh) | 2005-09-28 |
| EP1534667A1 (en) | 2005-06-01 |
| DK1534667T3 (da) | 2011-02-14 |
| US20060122280A1 (en) | 2006-06-08 |
| AU2003256791A1 (en) | 2004-03-11 |
| CN100554247C (zh) | 2009-10-28 |
| CA2493958C (en) | 2010-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2009000943A1 (es) | Metodos de preparacion de compuestos intermediarios del tipo pirazoles condensados para la preparacion de moduladores de los receptores de serotonina. (divisional solicitud n° 2384-04) | |
| NI200700270A (es) | Derivados benzodioxano y benzodioxolano y usos de los mismos | |
| UY26020A1 (es) | Inhibidores de la recaptacion de monoaminas para el tratamiento de trastornos del snc. | |
| AR004320A1 (es) | Nuevos compuestos de pirimidina condensados biciclicos; un procedimiento para su preparacion; composiciones farmaceuticas que los contienen y su usocomo agentes terapeuticos, en particular como inhibidores de la tirosina quinasa. | |
| UY27976A1 (es) | Piperazinas heterocíclicas sustituídas para el tratamiento de la esquizofrenia | |
| SE0202241D0 (sv) | Novel Compounds | |
| CO6321153A2 (es) | Derivados de cromeno y cromano y sus usos | |
| MX2007013021A (es) | Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c. | |
| PE20041040A1 (es) | Compuestos derivados de amidas como inhibidores de 11-beta-hidroxiesteroide-deshidroxigenasa de tipo 1 | |
| BRPI0415769A (pt) | alcanaminas de diidrobenzofuranila e composições farmacêuticas contendo-as | |
| AR030533A1 (es) | Compuestos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas, composicion farmaceutica, procedimiento de tratamiento intermediario | |
| BRPI0607532A2 (pt) | derivados de alcanamina de diidrobenzofuranila como agonistas de 5ht2c | |
| BRPI0410711A (pt) | novos compostos | |
| UY29212A1 (es) | Azabenzoxazoles para el tratamiento de trastornos del snc | |
| TW200621245A (en) | Thienopyridinone compounds and methods of treatment | |
| PE20061327A1 (es) | Combinaciones de derivados de benzofurano y un antidepresivo para el tratamiento o la prevencion de la depresion | |
| IS8377A (is) | Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns | |
| DE60305484D1 (de) | Verbindungen und deren verwendung als 5-ht inhibitore | |
| EA200500172A1 (ru) | Азабициклопроизводные в качестве антагонистов мускариновых рецепторов | |
| CY1108880T1 (el) | Παραγωγα καρβοξαμιδιου ως ανταγωνιστες μουσκαρινικου υποδοχεα | |
| PE20001084A1 (es) | Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas | |
| PE20081665A1 (es) | Antagonistas del receptor de dopamina 2 de rapida disociacion | |
| BRPI0409302A (pt) | derivados azabiciclo como antagonistas de recetores muscarìnicos, método para sua preparação e composição farmacêutica contendo os mesmos | |
| AR035818A1 (es) | Fenil-heterociclil-eteres con actividad como inhibidores selectivos de recaptacion de serotonina, composiciones farmaceuticas y su uso en la fabricacion de medicamentos | |
| PE20040894A1 (es) | Agonistas muscarinicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |